What does stable disease mean on my Triple-Negative Breast Cancer scan results

Understanding "Stable Disease" on Your Scan Results

Great question—this is an important finding to understand. Let me break down what "stable disease" means and why it matters for your Triple-Negative Breast Cancer (TNBC) care.

What "Stable Disease" Means

Stable disease means your cancer is not growing and not shrinking based on what the scan shows. The tumors are essentially staying the same size compared to your previous scan. This is one of four possible scan outcomes:

1. Complete response - All visible cancer is gone
2. Partial response - Cancer shrunk by at least 30%
3. Stable disease - Cancer size unchanged (within measurement variation)
4. Progressive disease - Cancer grew by 20% or more

Why This Matters for TNBC

Triple-Negative Breast Cancer is called "triple-negative" because it lacks three common receptors (ER, PR, and HER2) that make other breast cancers responsive to hormone therapy or HER2-targeted drugs. This means TNBC treatment typically relies on:

• Chemotherapy (the backbone of treatment)
• Immunotherapy (increasingly used for TNBC)
• Clinical trials with newer targeted approaches

According to discussions from leading oncologists in the CancerPatientLab webinar series, stable disease can actually represent a meaningful clinical outcome, especially when you consider:

The Clinical Perspective

Stable disease isn't failure—it's disease control. Your oncologist is likely evaluating:

• How long the disease has remained stable (longer is better)
• Your symptoms and quality of life while on treatment
• Side effects you're experiencing
• Whether your current treatment is working or needs adjustment

As noted in expert discussions about breast cancer management, the goal isn't always dramatic tumor shrinkage—it's controlling the cancer and maintaining your quality of life.

Important Questions to Ask Your Oncologist

Since you have stable disease, these questions will help you understand your specific situation:

1. How does this compare to my previous scans? Has the disease been stable for months, or is this the first stable scan?

2. Are there any biomarkers or genetic mutations in my tumor that might guide treatment decisions? (For TNBC, mutations like AKT1 or other actionable findings can inform therapy choices)

3. Should we continue the current treatment, or are there other options to consider, such as:

   • Different chemotherapy regimens
   • Immunotherapy combinations
   • Clinical trials for TNBC
   • CDK4/6 inhibitors (if your tumor has certain characteristics)

4. What are the signs that would prompt a treatment change? Understanding the "trigger points" helps you stay informed.

5. Are there any liquid biopsy tests (like circulating tumor DNA monitoring) that might help track your response more closely between scans?

The Bigger Picture

According to expert oncologists discussing breast cancer management, stable disease with good quality of life and manageable side effects can be a reasonable outcome, especially for TNBC where treatment options are more limited than for hormone-positive cancers. The focus shifts to:

• Maintaining disease control over time
• Preserving your quality of life
• Monitoring for any changes that would warrant treatment adjustment
• Staying alert to emerging treatment options specific to TNBC

Next Steps

Don't let "stable" sound passive—it's an active achievement. Work with your oncologist to:

• Understand whether continuing current treatment makes sense
• Discuss any new symptoms or side effects
• Plan your follow-up scan schedule
• Ask about any new TNBC-specific trials or treatments that might be appropriate for you

This information is for educational purposes only. Always consult your healthcare team for personalized medical advice and decisions.